A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published in Nature ...

Explore new findings on drug-resistant breast cancer and how targeting cell cycle regulators may improve treatment outcomes.

Metastasis and disease progression remain the leading causes of mortality in both breast and cervical cancer. These processes ...

SHENZHEN, GUANGDONG, CHINA, January 16, 2026 /EINPresswire.com/ -- The global demand for advanced energy storage ...

Cilia are evolutionarily conserved, microtubule-based organelles that project from the surface of most eukaryotic cells and play a central role in sensing ...

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Communications , identifies a powerful strategy to overcome drug resistance in ...

HOUSTON, JANUARY 22, 2026 ― A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center , published today in ...

Zydus has launched Tishtha, an affordable biosimilar of nivolumab, at nearly one-fourth the original price. Approved by the ...

WILMINGTON, DE — Colorectal cancer, long thought to begin when cells start growing out of control, may instead take root when ...

Perovskite solar cells have long been the most exciting “almost there” technology in clean ...

A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...